Press "Enter" to skip to content

New patent for Otsuka drug REXULTI

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for REXULTI
Annual Drug Patent Expirations for REXULTI

Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug.

REXULTI drug price trends.

Drug patent litigation for REXULTI.

This drug has sixty-five patent family members in thirty-seven countries.

The generic ingredient in REXULTI is brexpiprazole. Two suppliers are listed for this compound. Additional details are available on the brexpiprazole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions